| 167551 | 167551 | Safety and Efficacy of Cognitive Behavior Therapy for People With Post-Traumatic Stress and Cardiovascular Illness | Completed | No Results Available | Stress Disorders, Post-Traumatic | Behavioral: Cognitive behavioral therapy (CBT)|Behavioral: Educational session and treatment as usual | https://ClinicalTrials.gov/show/NCT00364910 |
| 167552 | 167552 | Investigation of Clinical Outcome of ACL Reconstruction Utilizing Two Tibial Fixation Techniques, Concentric Tapered Interference Screws and Interference Screw and Sheath | Withdrawn | No Results Available | Primary ACL Tears | | https://ClinicalTrials.gov/show/NCT00364897 |
| 167553 | 167553 | Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease | Not yet recruiting | No Results Available | Chronic Kidney Disease | Drug: ketoaminoacid | https://ClinicalTrials.gov/show/NCT00364884 |
| 167554 | 167554 | Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity | Completed | No Results Available | Obesity | Drug: naltrexone and bupropion SR | https://ClinicalTrials.gov/show/NCT00364871 |
| 167568 | 167568 | RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial | Recruiting | No Results Available | Hepatic Encephalopathy | Drug: Rifaximin alone, Rifaximin combined with Lactulose | https://ClinicalTrials.gov/show/NCT00364689 |
| 167555 | 167555 | Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease | Completed | Has Results | Gaucher Disease, Type 1|Cerebroside Lipidosis Syndrome|Glucocerebrosidase Deficiency Disease|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form | Drug: Cerezyme | https://ClinicalTrials.gov/show/NCT00364858 |
| 167556 | 167556 | STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients | Terminated | Has Results | Anemia|Chronic Kidney Disease | Drug: Darbepoetin alfa|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00364845 |
| 167569 | 167569 | Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease | Completed | No Results Available | Tumors|Hodgkins Disease|Non-Hodgkins Lymphoma | Drug: VLI|Drug: VLI | https://ClinicalTrials.gov/show/NCT00364676 |
| 167557 | 167557 | A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. | Completed | No Results Available | Anemia | Drug: methoxy polyethylene glycol-epoetin beta [Mircera] | https://ClinicalTrials.gov/show/NCT00364832 |
| 167558 | 167558 | Initial Study of Rituximab to Treat Primary Biliary Cirrhosis | Completed | No Results Available | Primary Biliary Cirrhosis | Drug: rituximab | https://ClinicalTrials.gov/show/NCT00364819 |
| 167559 | 167559 | A Clinical Trial Comparing Two Different Medications to Determine Which One is Better for Patients With an Acute Migraines in the Emergency Department | Completed | No Results Available | Migraine | Drug: Prochlorperazine|Drug: Metoclopramide | https://ClinicalTrials.gov/show/NCT00364806 |
| 167560 | 167560 | Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children | Completed | Has Results | HIV Infections | Drug: Efavirenz (EFV) + Didanosine (ddI) + Emtricitabine (FTC) | https://ClinicalTrials.gov/show/NCT00364793 |
| 167561 | 167561 | Study of XL647 in Subjects With Non-Small-Cell Lung Cancer | Completed | No Results Available | Non-small-cell Lung Cancer | Drug: XL647 | https://ClinicalTrials.gov/show/NCT00364780 |
| 167562 | 167562 | Moderate Alcohol Consumption, Fat and Carbohydrate Metabolism and Insulin Sensitivity | Completed | No Results Available | Diabetes Mellitus, Type 2|Cardiovascular Disease | Dietary Supplement: A|Dietary Supplement: B | https://ClinicalTrials.gov/show/NCT00364767 |
| 167563 | 167563 | Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer | Completed | No Results Available | Metastatic/Recurrent Breast Cancer | Drug: Tesmilifene (YMB 1002) | https://ClinicalTrials.gov/show/NCT00364754 |
| 167564 | 167564 | Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial) | Completed | No Results Available | Laparotomy | Drug: Oxygen | https://ClinicalTrials.gov/show/NCT00364741 |
| 167565 | 167565 | Efferocytosis and Genomic Polymorphism in Autoimmune Diseases | Recruiting | No Results Available | SLE|Rheumatoid Arthritis|Healthy Subjects | | https://ClinicalTrials.gov/show/NCT00364728 |
| 167566 | 167566 | Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer | Completed | No Results Available | Squamous Cell Carcinoma | | https://ClinicalTrials.gov/show/NCT00364715 |
| 167567 | 167567 | Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder | Completed | No Results Available | ADHD | Drug: methylphenidate | https://ClinicalTrials.gov/show/NCT00364702 |
| 167570 | 167570 | The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer | Recruiting | No Results Available | Non Small Cell Lung Cancer | | https://ClinicalTrials.gov/show/NCT00364663 |
| 167571 | 167571 | Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation | Completed | No Results Available | Immunosuppressant Associated Diarrhea | Drug: Probiotic Supplement|Other: Placebo | https://ClinicalTrials.gov/show/NCT00364650 |
| 167572 | 167572 | Volatile Anesthetics in Cardiac Protection | Recruiting | No Results Available | Anesthesia | Drug: Sevoflurane (Volatile Anesthetic)|Drug: Total intravenous anesthesia | https://ClinicalTrials.gov/show/NCT00364637 |
| 167573 | 167573 | Adrenal Function in Patients With Newly Diagnosed Lung Cancer | Completed | No Results Available | Lung Cancer|Adrenal Insufficiency | | https://ClinicalTrials.gov/show/NCT00364624 |
| 167574 | 167574 | Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer | Completed | Has Results | Breast Cancer | Drug: Bevacizumab|Drug: Docetaxel|Drug: Trastuzumab | https://ClinicalTrials.gov/show/NCT00364611 |
| 167575 | 167575 | Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant | Active, not recruiting | No Results Available | Heart Failure | Drug: Anginera, a human tissue replacement therapy | https://ClinicalTrials.gov/show/NCT00364598 |
| 167576 | 167576 | A Prospective Evaluation of the GreenLight Model 120 Laser | Completed | No Results Available | Benign Prostatic Hyperplasia | Device: GreenLight Model 120 Laser System | https://ClinicalTrials.gov/show/NCT00364585 |
| 167577 | 167577 | Efficacy of Epidural Etanercept in the Treatment of Sciatica | Completed | No Results Available | Sciatica | Drug: epidural injection of etanercept|Drug: placebo (control procedure) | https://ClinicalTrials.gov/show/NCT00364572 |
| 167578 | 167578 | Effect of Rosuvastatin in Intracerebral Hemorrhage | Completed | No Results Available | Intracerebral Hemorrhage|Stroke | Drug: Rosuvastatin | https://ClinicalTrials.gov/show/NCT00364559 |
| 167579 | 167579 | A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain | Completed | No Results Available | Osteoarthritis|Pain Intensity Assessment|Arthralgia|Sciatica|Low Back Pain | Drug: CG 5503;tapentadol | https://ClinicalTrials.gov/show/NCT00364546 |
| 167580 | 167580 | A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety | Terminated | Has Results | Arthroplasty | Drug: Tapentadol IR (CG5503)|Drug: Placebo|Drug: Oxycodone HCL IR|Drug: Tapentadol IR (CG5503) | https://ClinicalTrials.gov/show/NCT00364533 |